United Therapeutics (UTHR) Other Non Operating Income (2009 - 2026)

United Therapeutics (UTHR) has 18 years of Other Non Operating Income data on file, last reported at -$46.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 976.74% year-over-year to -$46.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 2400.0% YoY), and the FY2025 full-year result was $48.9 million, up 743.1% from the prior year.
• Other Non Operating Income eased to -$46.3 million in Q1 2026, from $47.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $47.2 million in Q4 2025 to a low of -$51.8 million in Q2 2022.
• A 5-year average of -$2.7 million and a median of -$600000.0 in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income sank 1818.52% in 2022 and soared 1915.38% in 2025, its largest moves.
• Tracing UTHR's Other Non Operating Income over 5 years: stood at -$5.3 million in 2022, then jumped by 88.68% to -$600000.0 in 2023, then sank by 333.33% to -$2.6 million in 2024, then soared by 1915.38% to $47.2 million in 2025, then slumped by 198.09% to -$46.3 million in 2026.
• Business Quant data shows UTHR's Other Non Operating Income at -$46.3 million in Q1 2026, $47.2 million in Q4 2025, and $6.1 million in Q3 2025.